IN2014MN01377A - - Google Patents
Info
- Publication number
- IN2014MN01377A IN2014MN01377A IN1377MUN2014A IN2014MN01377A IN 2014MN01377 A IN2014MN01377 A IN 2014MN01377A IN 1377MUN2014 A IN1377MUN2014 A IN 1377MUN2014A IN 2014MN01377 A IN2014MN01377 A IN 2014MN01377A
- Authority
- IN
- India
- Prior art keywords
- amorphous precipitated
- protein
- dry
- protein particles
- precipitated protein
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 239000006260 foam Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000012460 protein solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201122408A GB201122408D0 (en) | 2011-12-23 | 2011-12-23 | Method for preparing dry protein formulations |
| PCT/GB2012/053265 WO2013093524A2 (en) | 2011-12-23 | 2012-12-24 | Method for preparing amorphous precipitated protein particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01377A true IN2014MN01377A (cs) | 2015-04-17 |
Family
ID=45695047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1377MUN2014 IN2014MN01377A (cs) | 2011-12-23 | 2012-12-24 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20140348852A1 (cs) |
| EP (1) | EP2793863B1 (cs) |
| JP (1) | JP2015500869A (cs) |
| BR (1) | BR112014015357A2 (cs) |
| CA (1) | CA2859288A1 (cs) |
| DK (1) | DK2793863T3 (cs) |
| GB (1) | GB201122408D0 (cs) |
| IN (1) | IN2014MN01377A (cs) |
| WO (1) | WO2013093524A2 (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11174458B2 (en) * | 2007-04-23 | 2021-11-16 | Koligo Therapeutics, Inc. | Cell separation apparatus and methods of use |
| GB201313368D0 (en) * | 2013-07-26 | 2013-09-11 | Xstalbio Ltd | Novel Reconstitution devices |
| AU2017364077A1 (en) | 2016-11-22 | 2019-06-20 | Elektrofi, Inc. | Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof |
| AU2018306303A1 (en) | 2017-07-25 | 2020-02-20 | Elektrofi, Inc. | Formation of particles including agents |
| US20210101929A1 (en) * | 2018-04-16 | 2021-04-08 | Merck Patent Gmbh | Method for stabilizing protein comprising formulations by using a meglumine salt |
| BR112020022610A2 (pt) | 2018-05-10 | 2021-02-09 | Regeneron Pharmaceuticals, Inc. | proteína de fusão de receptor de vegf de alta concentração que contém formulações |
| US12115262B2 (en) | 2018-05-24 | 2024-10-15 | Elektrofi, Inc. | Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof |
| CN113365609A (zh) | 2019-01-31 | 2021-09-07 | 伊勒卓菲公司 | 颗粒形成和形态 |
| US20220119760A1 (en) * | 2019-02-05 | 2022-04-21 | Lindy Biosciences, Inc. | Isolated cell culture components and methods for isolating the same from liquid cell culture medium |
| CN115484934A (zh) | 2020-04-17 | 2022-12-16 | 伊勒卓菲公司 | 通过连续液滴形成和脱水形成颗粒的方法 |
| CN115844752B (zh) * | 2022-11-02 | 2024-06-28 | 上海铂舍生物科技有限公司 | 一种5d超分子胶原蛋白及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0300427D0 (en) | 2003-01-09 | 2003-02-05 | Univ Strathclyde | Pharmaceutical composition |
| GB0707938D0 (en) | 2007-04-25 | 2007-05-30 | Univ Strathclyde | Precipitation stabilising compositions |
-
2011
- 2011-12-23 GB GB201122408A patent/GB201122408D0/en not_active Ceased
-
2012
- 2012-12-24 EP EP12816095.9A patent/EP2793863B1/en not_active Not-in-force
- 2012-12-24 CA CA2859288A patent/CA2859288A1/en not_active Abandoned
- 2012-12-24 JP JP2014548209A patent/JP2015500869A/ja not_active Withdrawn
- 2012-12-24 US US14/367,088 patent/US20140348852A1/en not_active Abandoned
- 2012-12-24 IN IN1377MUN2014 patent/IN2014MN01377A/en unknown
- 2012-12-24 BR BR112014015357A patent/BR112014015357A2/pt not_active IP Right Cessation
- 2012-12-24 WO PCT/GB2012/053265 patent/WO2013093524A2/en not_active Ceased
- 2012-12-24 DK DK12816095.9T patent/DK2793863T3/en active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2793863B1 (en) | 2018-07-25 |
| EP2793863A2 (en) | 2014-10-29 |
| WO2013093524A2 (en) | 2013-06-27 |
| WO2013093524A3 (en) | 2013-08-15 |
| DK2793863T3 (en) | 2018-11-12 |
| GB201122408D0 (en) | 2012-02-08 |
| BR112014015357A2 (pt) | 2017-07-11 |
| JP2015500869A (ja) | 2015-01-08 |
| US20140348852A1 (en) | 2014-11-27 |
| CA2859288A1 (en) | 2013-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN01377A (cs) | ||
| MY167953A (en) | Flavoured rods for use in aerosol-generating articles | |
| GB201002249D0 (en) | Improvements in or relating to methods of manufacture | |
| MY166059A (en) | Fusion Proteins for Treating Metabolic Disorders | |
| ZA201403109B (en) | Modulating beta-damascenone in plants | |
| MY168396A (en) | Smoking article comprising menthol | |
| EP2529006A4 (en) | METHODS AND COMPOSITIONS FOR IMPROVING PROTEIN PRODUCTION | |
| PT2665818T (pt) | Expressão de proteínas em plantas | |
| PL2768935T3 (pl) | Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie | |
| HUE047737T2 (hu) | Nyújtott hatóanyag-felszabadítású készítmények fehérjék szembe történõ bejuttatásához, és eljárás ezek elõállítására | |
| EP2697640A4 (en) | PROCESS FOR PROFILING THE PHYTOHORMONE MIRROR IN PLANT TISSUE | |
| ZA201300275B (en) | Methods for producing proteins in plants | |
| ZA201403059B (en) | Increasing virus-like particle yield in plants | |
| IL230519B (en) | Virus-based vector constructs used to transform eukaryotic cells | |
| GB201115472D0 (en) | Improvements in or relating to wheels | |
| ZA201404560B (en) | Process for preparing sodium bicarbonate particles | |
| IN2015DN04074A (cs) | ||
| PL2714327T3 (pl) | Ulepszenia sposobów ostrzenia noży | |
| ZA201503737B (en) | Improved methods for inducing apomixis in plants | |
| HUE038004T2 (hu) | Módok és eljárások apomixis indukálására növényekben | |
| MX351994B (es) | Formas cristalinas de [(s)-1-carbamoil-2-(feniil-pirimidin-2-il-am ino)-etil]-amida del acido 2-(2-metilamino-pirimidin-4-il)-1h-indo l-5-carboxilico. | |
| MY166897A (en) | Stable compositions and methods for preparing the same | |
| IN2012CH02984A (cs) | ||
| GB201119652D0 (en) | Improvements in or relating to subsea power distribution | |
| GB201100425D0 (en) | Process & dressing |